Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling-Reference-Cited by-同舟云学术

Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling

Published:2017-01-06 Issue:3 Volume:91 Page:208-219
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Bender Andrew T.,Gardberg Anna,Pereira Albertina,Johnson Theresa,Wu Yin,Grenningloh Roland,Head Jared,Morandi Federica,Haselmayer Philipp,Liu-Bujalski Lesley

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference29 articles.

1. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer

2. Btk inhibition treats TLR7/IFN driven murine lupus;Bender;Clin Immunol,2016

3. The Src, Syk, and Tec family kinases: Distinct types of molecular switches

4. The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells;Chang;Arthritis Res Ther,2011

5. MolProbity: all-atom structure validation for macromolecular crystallography

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting breast cancer with rationally designed quinazolines: A scaffold hopping strategy;Journal of Molecular Structure;2024-11

2. Comprehensive Characterization of BTK Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Non-covalent Mechanistic Signatures;2024-09-08

3. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09

4. Discovery of orally available 1H-pyrazolo [3, 4-d] pyrimidin-4-amine derivative as a novel BTK inhibitor;Arabian Journal of Chemistry;2024-09

5. Exploring 2-Sulfonylpyrimidine Warheads as Acrylamide Surrogates for Targeted Covalent Inhibition: A BTK Story;Journal of Medicinal Chemistry;2024-08-09